Nanjing Vazyme Biotech Co., Ltd. (688105.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 6.53B |
| Enterprise Value | 6.54B |
| P/E Ratio | 4,052,519.09T |
| PEG Ratio | 15,666.87T |
| Price/Sales Ratio | 7.41 |
| Price/Book Ratio | 1.1 |
| Enterprise/Revenue | 7.57 |
| Enterprise/EBITDA | 113.32 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.01 |
| Operating Margin | -0.02 |
| Return On Assets | -0 |
| Return On Equity | -0 |
| Revenue | 1.38B |
| Revenue/Share | 7.84 |
| Gross Profit | -40.48M |
| EBITDA | 165.62M |
| Net Income | -16.97M |
| Diluted EPS | -0.04 |
| Total Cash | 2.51B |
| Total Cash/Share | 13.38 |
| Total Debt | 671.57M |
| Total Debt/Equity | 0.19 |
| Current Ratio | 3.99 |
| Book Value Per Share | 19.19 |
| 52-Week Change | 22.83 |
| 52-Week High | 29.16 |
| 52-Week Low | 12.89 |
| Moving Average 50 Days | 23.29 |
| Moving Average 200 Days | 17.91 |
| Average Volume | 14.47M |
| Shares Outstanding | 516.99M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.5 |
| Trailing Annual Dividend Yield | 2.37 |
| Payout Ratio | -23.05 |
| Last Split Factor | 13:10 |
| Last Split Date | June 03, 2026 |